Země: Irsko
Jazyk: angličtina
Zdroj: HPRA (Health Products Regulatory Authority)
Pancreas powder
Mylan IRE Healthcare Limited
A09AA; A09AA02
Pancreas powder
400 milligram(s)
Gastro-resistant capsule
Product subject to prescription which may be renewed (B)
Enzyme preparations; multienzymes (lipase, protease etc.)
Not marketed
2006-09-08
FRONT Colours Non-Print Colours Date: Time: Dimensions Main Font Body Text Size Min Text Size used Page Count No. of colours Pharma Code SAP No. Vendor Job No. Trackwise Proof No. Client Market Keyline/Drawing No. Barcode Info 3D Render ID Description Component Type TrackWise PR No. MA No. Packing Site/Printer Supplier Code Sign-offs Equivalent Pantone+ Color Bridge Coated colours v3/July 2017 Creon 10000 and 25000 gastro-resistant capsules, 150 mg, 300 mg, 50, 100 07 JUN 2019 13:20 Leaflet (Insert) 389 1871729 400542282 400542311 N.A. N.A. 2 Black 1 8 pt 8 pt 1871729 1 PA 2010/8/1 Ireland ABT (Neustadt - DE) N.A. 1122638 N.A. Helvetica Neue N.A. 300*141mm Cutting Die P. 3025 C 1122638 PACKAGE LEAFLET: INFORMATION FOR THE USER Creon 10000 Gastro-resistant Capsules Creon 25000 Gastro-resistant Capsules Creon 40000 Gastro-resistant Capsules pancreatin Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor, pharmacist or nurse. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. What is in this leaflet: 1. What Creon is and what it is used for 2. What you need to know before you take Creon 3. How to take Creon 4. Possible side effects 5. How to store Creon 6. Contents of the pack and other information 1. WHAT CREON IS AND WHAT IT IS USED FOR What Creon is • Creon contains an enzyme mixture called “pancreatin”. • Pancreatin helps you digest food. The enzymes are taken from pig pancreas glands. • Creon gastro-resistant capsules contain small pellets which slowly release the pancreatin in your gut (gastro-resistant pellets, called Minimicrospheres™). What Creon is used for • Cr Přečtěte si celý dokument
Health Products Regulatory Authority 02 August 2019 CRN008LL2 Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Creon 40000 Gastro-resistant Capsules 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each capsule contains 400 mg pancreatin equivalent to: Lipase 40,000 Ph.Eur. units Amylase 25,000 Ph. Eur. units Protease 1,600 Ph. Eur. units Produced from porcine pancreatic tissue. For a full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Gastro-resistant Capsule, hard Brown/clear size 00 hard gelatin capsule containing light brown, gastro-resistant granules 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For the treatment of pancreatic exocrine insufficiency. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION _Adults (including the elderly) and children:_ Creon 40000 should only be used if the patient requires equal to or more than 40,000 lipase units per meal or snack. Initially one or two capsules during or immediately after meals. The capsules should be swallowed whole, without crushing or chewing, with enough fluid during or after each meal or snack. Dose adjustments, if required, should be done slowly, with careful monitoring of response and symptomatology. When swallowing of capsules is difficult (e.g. small children or elderly patients), the capsules may be carefully opened and the minimicrospheres added to acidic soft food [pH < 5.5] that does not require chewing, or the minimicrospheres will be taken with acidic liquid [pH < 5.5]. This could be apple sauce or yoghurt or fruit juice with a pH less than 5.5, e.g. apple, orange or pineapple juice. This mixture should not be stored. Crushing and chewing of the minimicrospheres or mixing with food or fluid with a pH greater than 5.5 can disrupt the protective enteric coating. This can result in the early release of enzymes in the oral cavity and may lead to reduced efficacy and irritation of the mucous membranes. Care should be taken that no product is retained in the mouth. It is important to ensure adequate hydration of patients a Přečtěte si celý dokument